Cuttign edge: Novel RNA lingands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function

Journal of Immunology

Volumn 160, Issue 11, 1998, Pages 5209-5212

  Kraus, Elmar ^a   James, William ^b   Barclay, A Neil ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; LIGAND BINDING; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; ANIMAL; BINDING SITE; CD4+ T LYMPHOCYTE; DRUG EFFECT; GENETIC PROCEDURES; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE; RAT STRAIN;

CD4 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LIGAND; OLIGONUCLEOTIDE; PURINE NUCLEOTIDE; PYRIMIDINE NUCLEOTIDE; RECOMBINANT PROTEIN; RNA; SEPHAROSE;

ANIMALS; ANTIGENS, CD4; BINDING SITES; BIOSENSING TECHNIQUES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIGANDS; LYMPHOCYTE CULTURE TEST, MIXED; OLIGONUCLEOTIDES; PURINE NUCLEOTIDES; PYRIMIDINE NUCLEOTIDES; RATS; RATS, INBRED STRAINS; RECOMBINANT PROTEINS; RNA; SEPHAROSE;

EID: 0032081316     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Griffiths, A. D., S. C. Williams, O. Hartley, I. M. Tomlinson, P. Waterhouse, W. L. Crosby, R. E. Kontermann, P. T. Jones, N. M. Low, T. J. Allison, T. D. Prospero, H. R. Hoogenboom, A. Nissim, J. P. L. Cox, J. L. Harrison, M. Zaccolo, E. Gherardi, and G. Winter. 1994. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:3245.
2. Gold, L., B. Polisky, O. Uhlenbeck, and M. Yarus. 1995. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64:763.
3. Ellington, A. D., and J. W. Szostak. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346:818.
4. Tuerk, C., and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage-T4 DNA-polymerase. Science 249: 505.
5. Pieken, W. A., D. B. Olson, F. Benseler, H. Aurup, and F. Eckstein. 1991. Kinetic characterization of nuclease-resistant 2′-modified hammerhead ribozymes. Science 253:314.
6. Lin, Y., Q. Qui, S. C. Gill, and S. D. Jayasena. 1994. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res. 22:5229.
7. Green, L. S., D. Jellinek, C. Bell, L. A. Beebe, B. D. Feismer, S. C. Gill, F. M. Jucker, and N. Janjic. 1995. Nuclease-resistant nucleic-acid ligands to vascular-permeability factor vascular endothelial growth-factor. Chem. Biol. 2:683.
8. Jellinek, D., L. S. Green, C. Bell, C. K. Lynott, N. Gill, C. Vargeese, G. Kirschenheuter, D. P. C. McGee, P. Abesinghe, W. A. Pieken, R. Shapiro, D. B. Rifkin, D. Moscatelli, and N. Janjic. 1995. Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34:11363.
9. Pagratis, N. C., C. Bell, Y. F. Chang, S. Jennings, T. Fitzwater, D. Jellinek, and C. Dang. 1997. Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat. Biotechnol. 15:68.
10. Dagleish, A. G., P. C. L. Beverly, P. R. Clapham, M. F. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763.
11. Simon, J. H. M., C. Somoza, G. A. Schockmel, M. Collin, S. J. Davis, A. F. Williams, and W. James. 1993. A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection. J. Exp. Med. 177:949.
12. Corbeau, P., R. Benkirane, C. Weil, S. David, S. Emiliani, D. Olive, C. Mawas, A. Serre, and C. Devaux. 1993. Ig CDR-3-like region of CD4 is involved in syncytia formation but not in viral entry. J. Immunol. 150:290.
13. Truneh, A., D. Buck, D. R. Cassat, R. Juzszak, S. Kassis, S. E. Ryu, D. Healey, R. Sweet, and Q. Sattenau. 1991. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion. J. Biol. Chem. 266:5942.
14. Simon, J. H. M., P. Stumbles, N. Signoret, C. Somoza, M. Puklavec, Q. J. Sattentau, A. N. Barclay, and W. James. 1997. Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1. J. Virol. 71:1476.
15. Cobbold, S. P., E. Adams, S. E. Marshall, J. D. Davies, and H. Waldmann. 1996. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol. Res. 149:5.
16. Fitzwater, T., and B. Polisky. 1996. A SELEX primer. Methods Enzymol. 267:275.
17. Heidenreich, O., S. H. Kang, D. A. Brown, X. Xu, P. Swiderski, J. J. Rossi, F. Eckstein, and M. Nerenberg. 1995. Ribozyme-mediated RNA degradation in nuclei suspension. Nucleic Acids Res. 23:2223.
18. Davis, S. J., R. L. Brady, A. N. Barclay, K. Harlos, G. G. Dodson, and A. F. Williams. 1990. Crystallization of a soluble form of the rat T-cell surface glycoprotein CD4 complexed with Fab from the W3/25 monoclonal antibody. J. Mol. Biol. 213:7.
19. Brady, R., E. Dodson, G. Dodson, G. Lange, S. Davies, A. F. Williams, and A. N. Barclay. 1993. Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains. Science 260:979.
20. Hsiung, L. M., A. N. Barclay, M. R. Brandon, E. Sim, and R. R. Porter. 1982. Purification of human C3b inactivator by monoclonal-antibody affinity chromatography. Biochem. J. 203:293.
21. Brideau, R. J., P. B. Carter, W. R. McMaster, and M. Webb. 1980. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur. J. Immunol 10:609.
22. Kubik, M. F., C. Bell, T. Fitzwater, S. R. Watson, and D. M. Tasset. 1997. Isolation and characterization of 2′-fluoro-, 2′-amino-, and 2′-fluoro-/aminomodified RNA ligands to human IFN-gamma that inhibit receptor binding. J. Immunol. 159:259.
23. Weiss, S., D. Proske, M. Neumann, M. H. Groschup, H. A. Kretschmar, M. Famulok, and E.-L. Winnacker. 1997. RNA aptamers specifically interact with the prion protein PrP. J. Virol 71:8790.
24. Mason, D., and A. F. Williams. 1990. The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem. J. 187:1.
25. Wiegand, T. W., P. B. Williams, S. C. Dreskin, M. H. Jouvin, J. P. Kinet, and D. Tasset. 1996. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fcε receptor I. J. Immunol. 157:221.
26. Webb, M., D. W. Mason, and A. F. Williams. 1979. Inhibition of a mixed lymphocyte response by a monoclonal antibody specific for a rat T lymphocyte subset. Nature 282:841.
27. Hicke, B. J., S. R. Watson, A. Koenig, C. K. Lynott, R. F. Bargatze, Y. F. Chang, S. Ringquist, L. Moon-McDermot, S. Jennings, T. Fitzwater, H. L. Han, N. Varki, I. Albinana, M. C. Willis, A. Varki, and D. Parma. 1996. DNA aptamers block L-selectin function in vivo: inhibition of human lymphocyte trafficking in SCID mice. J. Clin. Invest. 98:2688.
28. Bless, N. M., D. Smith, J. Charlton, B. J. Czermak, H. Schmal, H. P. Friedl, and P. A. Ward. 1997. Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury. Curr. Biol. 7:877.